Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,559 | 575 | 82.1% |
| Unspecified | $1,698 | 5 | 16.3% |
| Education | $161.85 | 5 | 1.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,689 | 48 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,039 | 61 | $0 (2024) |
| Dermavant Sciences, Inc. | $904.84 | 70 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $674.11 | 51 | $0 (2024) |
| PFIZER INC. | $605.51 | 37 | $0 (2024) |
| Celgene Corporation | $574.49 | 34 | $0 (2024) |
| Amgen Inc. | $443.77 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $441.68 | 45 | $0 (2024) |
| LEO Pharma Inc. | $429.35 | 28 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $357.89 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,742 | 217 | ABBVIE INC. ($2,215) |
| 2023 | $1,543 | 103 | Dermavant Sciences, Inc. ($270.55) |
| 2022 | $356.54 | 24 | Lilly USA, LLC ($80.74) |
| 2021 | $330.19 | 22 | Almirall LLC ($114.46) |
| 2020 | $266.66 | 18 | VYNE Pharmaceuticals Inc. ($67.72) |
| 2019 | $445.37 | 30 | PFIZER INC. ($160.04) |
| 2018 | $859.69 | 75 | Celgene Corporation ($200.86) |
| 2017 | $1,876 | 96 | Galderma Laboratories, L.P. ($570.64) |
All Payment Transactions
585 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $64.95 | General |
| Category: Immunology | ||||||
| 12/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.22 | General |
| Category: Immunology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.78 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Celgene Corporation | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Immunology | ||||||
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study | ABBVIE INC. | $1,698 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,461 | 2,511 | $829,060 | $255,925 |
| 2022 | 18 | 845 | 1,429 | $379,395 | $115,020 |
| 2021 | 18 | 831 | 1,562 | $440,658 | $125,481 |
| 2020 | 10 | 460 | 953 | $168,745 | $45,628 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 83 | 97 | $179,450 | $44,586 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 344 | 536 | $104,520 | $39,382 | 37.7% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 45 | 69 | $44,850 | $25,921 | 57.8% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 31 | 35 | $29,750 | $18,822 | 63.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 169 | 204 | $71,400 | $17,305 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 150 | $33,750 | $15,532 | 46.0% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 13 | 15 | $33,000 | $12,370 | 37.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 119 | 203 | $60,900 | $10,100 | 16.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 117 | 117 | $29,250 | $9,264 | 31.7% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 13 | 13 | $14,300 | $8,770 | 61.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 30 | 31 | $26,350 | $7,720 | 29.3% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 11 | 11 | $24,750 | $7,549 | 30.5% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 27 | 27 | $47,250 | $6,960 | 14.7% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 13 | 17 | $11,050 | $6,126 | 55.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 37 | 58 | $29,000 | $5,875 | 20.3% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 17 | 17 | $16,150 | $4,348 | 26.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 84 | 674 | $33,700 | $3,981 | 11.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 63 | 82 | $12,300 | $3,867 | 31.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $10,400 | $3,862 | 37.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 47 | $8,225 | $2,161 | 26.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 29 | 37 | $8,325 | $1,394 | 16.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 30 | 39 | $390.00 | $31.85 | 8.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 346 | $67,470 | $25,284 | 37.5% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 29 | 32 | $59,200 | $17,819 | 30.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 108 | 126 | $44,100 | $11,273 | 25.6% |
About Dr. Margarita Lolis, MD
Dr. Margarita Lolis, MD is a Procedural Dermatology healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2010. The National Provider Identifier (NPI) number assigned to this provider is 1881913713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Margarita Lolis, MD has received a total of $10,419 in payments from pharmaceutical and medical device companies, with $4,742 received in 2024. These payments were reported across 585 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,559).
As a Medicare-enrolled provider, Lolis has provided services to 3,597 Medicare beneficiaries, totaling 6,455 services with total Medicare billing of $542,054. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Procedural Dermatology
- Location Hackensack, NJ
- Active Since 05/17/2010
- Last Updated 06/25/2025
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1881913713
Products in Payments
- BOTOX (Biological) $1,809
- VTAMA (Drug) $904.84
- Otezla (Drug) $627.15
- EUCRISA (Drug) $605.51
- EPIDUO FORTE (Drug) $582.85
- Sotyktu (Drug) $441.34
- Winlevi (Drug) $439.68
- ENSTILAR (Drug) $373.04
- Humira (Biological) $288.48
- DORYX (Drug) $233.31
- DUPIXENT (Biological) $225.05
- TALTZ (Drug) $223.83
- Zoryve (Drug) $196.00
- SOOLANTRA (Drug) $173.82
- Seysara (Drug) $173.26
- Bimzelx (Biological) $147.80
- TREMFYA (Drug) $137.57
- Erivedge (Biological) $134.16
- RINVOQ (Biological) $133.04
- BLU-U (Medical Supply) $128.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.